Enhanced cyclosporine - Itraconazole interaction with cola in lung transplant recipients

Clinical Transplantation

Volumn 15, Issue 2, 2001, Pages 116-122

  Wimberley, Sl ^a   Haug III, Mt ^b,c   Shermock, Km ^b   Qu, A ^b   Maurer, Jr ^b   Mehta, Ac ^b   Schilz, Rj ^b   Gordon, Sm ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Aspergillosis; Cyclosporine; Drug interactions; Itraconazole; Lung transplant

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AZATHIOPRINE; CEFUROXIME; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOSPORIN; CYCLOSPORIN A; DAPSONE; GANCICLOVIR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERIMMUNE GLOBULIN; ITRACONAZOLE; METHYLPREDNISOLONE; MICONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PREDNISONE; PROTON PUMP INHIBITOR; SALBUTAMOL; TACROLIMUS;

ACIDITY; ARTICLE; ASPERGILLOSIS; BEVERAGE; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG COST; FEEDING; FOOD DRUG INTERACTION; HUMAN; INCIDENCE; INFECTION; LUNG FIBROSIS; LUNG TRANSPLANTATION; MEDICAL DOCUMENTATION; MORBIDITY; MORTALITY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RECIPIENT; STATISTICS; UNITED STATES;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CARBONATED BEVERAGES; CYCLOSPORINE; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES;

EID: 0035096501     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.150206.x     Document Type: Article

References (18)

1. Unilateral lung transplantation for pulmonary fibrosis
2. Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) Report
3. Aspergillus infection in single and double lung transplant recipients
4. Management of the transplant recipient with pulmonary infection
5. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
6. Aspergillus and lung transplant recipients: A mycologic and molecular epidemiologic study
7. Longitudinal data analysis using generalized linear models
8. Inference and missing data
9. Pharmacokinetics of itraconazole oral solution in allogenic bone marrow transplant patients receiving total body irradiation
10. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers
11. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole
12. Itraconazole: Pharmacokinetics and indications
13. Pharmacokinetics of itraconazole following oral administration to normal volunteers
14. Update on drug interactions with azole antifungal agents
15. Cyclosporine and itraconazole interaction in heart transplant recipients
16. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)
17. Ketoconazole versus itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: Preliminary results of two randomized studies